OPEN END TURBO PUT WARRANT - AMGEN | Market Closed - Deutsche Boerse AG 13:29:46 2024-06-28 EDT | ||
| 0.203 EUR | -2.40% |
|
| Current month | -27.50% | ||
| 1 month | -38.48% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 0.203 | -2.40% |
| 24-06-27 | 0.208 | +0.48% |
| 24-06-26 | 0.207 | +40.82% |
| 24-06-25 | 0.147 | -23.44% |
| 24-06-24 | 0.192 | -19.33% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 01:29 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UK0M5E |
| ISIN | DE000UK0M5E8 |
| Date issued | 2022-04-25 |
| Strike | 335 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 1 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.32 € |
|---|---|
| Lowest since issue | 0.1 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
